patients and pharma

Views & Analysis

Patient-centric programmes that ignore the ‘BREATHE’ principles will fail to hit the mark and leave patients behind, according to NexGen Healthcare.

News

A failed phase 2 study has undermined Novartis' hopes of extending the approved indications for Fabhalta to include lupus nephritis.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.